Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use Sancuso (Granisetron Transdermal System) safely and effectively. See full prescribing information for Sancuso. Sancuso (Granisetron Transdermal System) Initial U.S. Approval: 2008
Medication labelWhy this: Advisory · dailymed-prescription
Sancuso® (Granisetron Transdermal System) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration.
- generic_name
- granisetron
- product_names
- granisetron
- ndc
- 54868-5985, 42747-726, 54868-5985-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en